No Data
No Data
Bluebird Bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4)
bluebird bio, Inc. (NASDAQ:BLUE) today announced that the Compensation Committee of the Company's Board of Directors approved an inducement grant of stock options to purchase a total of 300,000 shares of common stock to
2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
2Flo Ventures, an emerging venture capital firm and startup studio focused on the discovery, development, and commercialization of healthcare...
BioLineRx Stock Jumps 14% on St. Jude Clinical Trial for Mitoxafortide
Bluebird Bio Announces CFO Transition and Compensation Details
Bluebird Bio Says Continuing To Work Expeditiously To Complete Delayed Filings
On March 26, 2024, bluebird announced that it will restate its consolidated financial statements for the first three quarters and full-year 2022, as well as the first three quarters of 2023. As a resu
Bluebird bio Inc - Appointed Chief Financial Officer (CFO) effective June 10, 2024
Bluebird bio Inc - Appointed Chief Financial Officer (CFO) effective June 10, 2024